Coherus Oncology News, Coherus Oncology Quote, CHRS Quote

Coherus Oncology (NQ:CHRS) Delayed: 1.41 -0.06 (4.08%)

Prev. Close

$1.47

Today 6M 1Y 5Y

Open

$1.48

52 Wk High

$31.98

52 Wk Low

$12.04

Day High

$1.48

Day Low

$1.40

P/E

N/A

EPS

$-0.10

Volume

437,184

Friends, Peers and Foes (?): ALLO, ELVN, ONCY PYXS (more...)

ALERTS | RSS

Jul 27, 2026 04:26 PM Form SCHEDULE 13G Coherus Oncology, Inc. Filed by: BlackRock, Inc.
Jul 22, 2026 01:36 PM Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026
Jun 23, 2026 02:09 PM Coherus and Zumutor to run Phase 1 trial combining ZM008 and Loqtorzi
Jun 23, 2026 02:00 PM Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
Jun 15, 2026 04:41 PM Form 8-K Coherus Oncology, Inc. For: Jun 12
Jun 9, 2026 09:58 PM Form 4 Coherus Oncology, Inc. For: Jun 05 Filed by: Satvat Ali J.
Jun 9, 2026 06:43 PM Form 4 Coherus Oncology, Inc. For: Jun 05 Filed by: Karachun Rita A
Jun 9, 2026 06:43 PM Form 4 Coherus Oncology, Inc. For: Jun 05 Filed by: Newcomer Lee Nisley
Jun 9, 2026 06:42 PM Form 4 Coherus Oncology, Inc. For: Jun 05 Filed by: Ryan Michael Lee
Jun 9, 2026 06:41 PM Form 4 Coherus Oncology, Inc. For: Jun 05 Filed by: O'Donnell-Tormey Jill

Entities mentioned with CHRS

View All Entities